Main Sector
Pharma (fully integrated)
Subsectors
Antibodies
Anti-infectives
Cell therapy
Gene therapy
Peptides
Proteins
Vaccines
Microbiome
Indications
Infectious and parasitic diseases / infectiology / parasitology
Neoplasms / cancer / oncology
Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
Endocrine, nutritional and metabolic diseases / endocrinology
Mental and behavioural disorders / psychiatry /psychology
Diseases of the nervous system / neurology
Cardiovascular / cardiology
Respiratory / pulmonology
Digestive system / gastroenterology
Skin and subcutaneous tissue / dermatology
Musculoskeletal system and connective tissue / Orthopedics
Genitourinary system / Urology
Congenital malformations, deformations and chromosomal abnormalities / medical genetics
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Injury, poisoning and certain other consequences of external causes / toxicology
Products
In development: 92
On the market: 71
Description
Takeda Pharmaceutical Company is a global, research-driven biopharmaceutical company headquartered in Tokyo, Japan, focused on discovering, developing, manufacturing, and commercializing innovative medicines across oncology, gastroenterology, neuroscience, rare diseases, plasma-derived therapies, immunology, and vaccines. The company's commercial portfolio includes products such as Entyvio, Takhzyro, FRUZAQLA, Qdenga, Livtencity, Velcade, and Adcetris, while its clinical pipeline spans cell...
